Dr. Mousa Selected as Guest Editor of Publication on Anti-Angiogenesis Therapeutics in Cancer
PRI Executive Director Shaker A. Mousa has been chosen to serve as Guest Editor of a special issue of the journal Biomedicines that will be focused on Anti-Angiogenesis Therapeutics in Cancer.
This Special Issue seeks to cover the current status and future directions in the discovery and development of novel anti-angiogenesis
strategies in Oncology. It is aimed to cover preclinical and clinical steps involved in the discovery and development of anti-angiogenesis targets in cancer and to discuss mechanisms involved in the modulation of angiogenesis in relation to cancer therapy.
FDA approved anti-angiogenesis agents in cancer therapeutics and limitations will be reviewed. Furthermore, the implications of Nanotechnology in expanding the utility of existing and new novel anti-angiogenesis strategies in cancer will also be reviewed.
The deadline for manuscript submissions is March 30, 2017.
Back to news